| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |